INTRODUCTION: Expression of adhesion molecules such as alphavbeta3 integrin has been associated with the metastatic potential of tumor cells. The purpose of this study was to determine whether alphavbeta3 expression correlated with the metastatic potential of human osteosarcoma cells. MATERIALS AND METHODS: We developed a series of sublines (LM2-LM7) from human osteosarcoma SAOS parental cells, with progressively increasing potential to form lung metastases in nude mice after intravenous injection. SAOS parental and LM2 cells were poorly metastatic, but LM7 cells resulted in visible metastatic lung nodules by 6-8 weeks. We quantified alphavbeta3 integrin expression using flow cytometry. RESULTS: alphavbeta3 expression correlated with the metastatic potential of the cells, with LM7 cells showing the highest expression. LM7 cell adhesion to vitronectin decreased after treatment with echistatin, a RGD-containing peptide antagonist of alphavbeta3. LM7 cells demonstrated higher chemotactic activity than SAOS cells to a homogenate made from lung tissue. This chemotactic activity was also inhibited by echistatin. These data indicated that alphavbeta3 was critical for the migration of LM7 cells to the lung homogenate. Chemotaxis to a liver homogenate was the same for LM7 and SAOS cells. Migration of LM7 cells through lung endothelial cells was higher than that through liver endothelial cells, and echistatin again inhibited this migration. CONCLUSIONS: alphavbeta3 integrin expression may play a role in the metastatic potential of osteosarcoma cells by enhancing the ability of the cells to migrate specifically to the lung. Alphavbeta3 integrin may therefore be a potential new target for osteosarcoma.
INTRODUCTION: Expression of adhesion molecules such as alphavbeta3 integrin has been associated with the metastatic potential of tumor cells. The purpose of this study was to determine whether alphavbeta3 expression correlated with the metastatic potential of humanosteosarcoma cells. MATERIALS AND METHODS: We developed a series of sublines (LM2-LM7) from humanosteosarcoma SAOS parental cells, with progressively increasing potential to form lung metastases in nude mice after intravenous injection. SAOS parental and LM2 cells were poorly metastatic, but LM7 cells resulted in visible metastatic lung nodules by 6-8 weeks. We quantified alphavbeta3 integrin expression using flow cytometry. RESULTS: alphavbeta3 expression correlated with the metastatic potential of the cells, with LM7 cells showing the highest expression. LM7 cell adhesion to vitronectin decreased after treatment with echistatin, a RGD-containing peptide antagonist of alphavbeta3. LM7 cells demonstrated higher chemotactic activity than SAOS cells to a homogenate made from lung tissue. This chemotactic activity was also inhibited by echistatin. These data indicated that alphavbeta3 was critical for the migration of LM7 cells to the lung homogenate. Chemotaxis to a liver homogenate was the same for LM7 and SAOS cells. Migration of LM7 cells through lung endothelial cells was higher than that through liver endothelial cells, and echistatin again inhibited this migration. CONCLUSIONS: alphavbeta3 integrin expression may play a role in the metastatic potential of osteosarcoma cells by enhancing the ability of the cells to migrate specifically to the lung. Alphavbeta3 integrin may therefore be a potential new target for osteosarcoma.
Authors: M P Link; A M Goorin; A W Miser; A A Green; C B Pratt; J B Belasco; J Pritchard; J S Malpas; A R Baker; J A Kirkpatrick Journal: N Engl J Med Date: 1986-06-19 Impact factor: 91.245
Authors: C C Kumar; M Malkowski; Z Yin; E Tanghetti; B Yaremko; T Nechuta; J Varner; M Liu; E M Smith; B Neustadt; M Presta; L Armstrong Journal: Cancer Res Date: 2001-03-01 Impact factor: 12.701
Authors: Robert R Langley; Karen M Ramirez; Rachel Z Tsan; Melissa Van Arsdall; Monique B Nilsson; Isaiah J Fidler Journal: Cancer Res Date: 2003-06-01 Impact factor: 12.701
Authors: Patrick J Messerschmitt; Ashley N Rettew; Robert E Brookover; Ryan M Garcia; Patrick J Getty; Edward M Greenfield Journal: Clin Orthop Relat Res Date: 2008-07-08 Impact factor: 4.176
Authors: Daniel Zuch; An-Hoa Giang; Yuriy Shapovalov; Edward Schwarz; Randy Rosier; Regis O'Keefe; Roman A Eliseev Journal: J Cell Biochem Date: 2012-04 Impact factor: 4.429
Authors: Daniel G Fuja; Nino C Rainusso; Ryan L Shuck; Lyazat Kurenbekova; Lawrence A Donehower; Jason T Yustein Journal: Am J Cancer Res Date: 2018-09-01 Impact factor: 6.166
Authors: Shikhar Vohra; Kristin M Hennessy; Amber A Sawyer; Ya Zhuo; Susan L Bellis Journal: J Mater Sci Mater Med Date: 2008-07-15 Impact factor: 3.896
Authors: Nabil Ahmed; Vita S Salsman; Eric Yvon; Chrystal U Louis; Laszlo Perlaky; Winfried S Wels; Meghan K Dishop; Eugenie E Kleinerman; Martin Pule; Cliona M Rooney; Helen E Heslop; Stephen Gottschalk Journal: Mol Ther Date: 2009-06-16 Impact factor: 11.454